These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
863 related articles for article (PubMed ID: 12224000)
1. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000 [TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia. Kaya E; Erkurt MA; Aydogdu I; Kuku I; Ozhan O; Oner RI; Ulutas O Med Princ Pract; 2007; 16(2):100-6. PubMed ID: 17303943 [TBL] [Abstract][Full Text] [Related]
3. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol. Schiavotto C; Castaman G; Rodeghiero F Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755 [TBL] [Abstract][Full Text] [Related]
4. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases. Li HQ; Zhang L; Zhao H; Ji LX; Yang RC Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M; Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672 [TBL] [Abstract][Full Text] [Related]
9. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center. Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult]. Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269 [TBL] [Abstract][Full Text] [Related]
11. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C; Reu FJ; Ho AD; Hensel M Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [TBL] [Abstract][Full Text] [Related]
12. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review. Gibson M; Sehon JK; White S; Zibari GB; Johnson LW Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623 [TBL] [Abstract][Full Text] [Related]
14. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura. Dan K; Gomi S; Kuramoto A; Maekawa T; Nomura T Int J Hematol; 1992 Jun; 55(3):287-92. PubMed ID: 1498319 [TBL] [Abstract][Full Text] [Related]
15. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Rodeghiero F Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569 [TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China. Zhou H; Fu R; Wang H; Zhou F; Li H; Zhou Z; Zhang L; Yang R Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151 [TBL] [Abstract][Full Text] [Related]
17. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins. Rodeghiero F; Schiavotto C; Castaman G; Vespignani M; Ruggeri M; Dini E Haematologica; 1992; 77(3):248-52. PubMed ID: 1330848 [TBL] [Abstract][Full Text] [Related]
18. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients. Aleem A Platelets; 2011; 22(1):1-7. PubMed ID: 20964585 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura. Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360 [TBL] [Abstract][Full Text] [Related]
20. Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura. Johansson E; Engervall P; Landgren O; Grimfors G; Widell S; Rezai S; Björkholm M Eur J Haematol; 2006 Jul; 77(1):61-6. PubMed ID: 16573739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]